JHS
JHS Svendgaard Laboratories financials
- Market cap
- ₹74 Cr
- Sector
- Fast Moving Consumer Goods
What JHS Svendgaard Laboratories Limited does
JHS Svendgaard Laboratories manufactures oral-care and personal-care products — toothbrushes, toothpastes, mouthwashes, denture tablets, whitening gels and talcum powder — on a contract/private-label basis for FMCG brands such as Dabur, Patanjali, Amway, HUL (Close Up), Reliance Consumer Products and Jyothy Labs. All production is concentrated at one integrated campus in Kala Amb, Himachal Pradesh, combining mechanical (toothbrush moulding/bristling) and chemical (toothpaste/liquid) manufacturing under one roof. It earns as an OEM/private-label supplier rather than through its own retail brand, and has recently diversified into talcum powder and expanded export sales into the US and Middle East.
Segments
- Toothbrushes
- Toothpastes
- Mouthwash & denture tablets
- Talcum powder
- Manufacturing campus
- Kala Amb, Himachal Pradesh — 20 acres, 6 integrated units (3 toothbrush, 2 toothpaste, 1 talcum)
- Toothbrush injection-moulding machines
- ~64 (33+4 horizontal, 27 vertical, 4 rotary) from Demag, Cincinnati, L&T, Haitian
- Bristling/tufting machines
- 74 (Zahoransky Germany, Boucherie Belgium, Alpha Plus Taiwan)
- Toothpaste high-speed filling lines
- 7+1 lines, 120–150 TPM (Wimco)
- Talcum manufacturing capacity
- Expanded from 3,000 to 10,000 units in FY25
- Export markets
- 9+ countries (incl. Mongolia, China, Iran, Saudi Arabia, Bangladesh, Thailand, Ethiopia, Australia), plus new entries into the US (Orazen Inc.) and Middle East (Classico Brands) in FY25
Quarterly results
Q1 FY27: revenue up 29.6%, net profit up 2.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20 | 23 | 25 | 23 | 22 +13% | 23 +3% | 33 +30% | 30 +30% |
| EBITDA | -1 | 0 | -5 | 2 | 1 +208% | 2 +568% | -2 +70% | 2 +25% |
| Net profit | -10 | -2 | -7 | 1 | -0 +98% | 1 +143% | -4 +49% | 1 +3% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −27.3% 1Y
1Y: ₹11.59 on 10 Sept 2025 → ₹8.43. High ₹13.56 (24 Oct 2025), low ₹6.55 (30 Mar 2026).
Financials, as filed
Revenue grew 19.9% a year over 2 years, FY24 to FY26. Operating margin widened to 2.6%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹71 Cr | ₹92 Cr | ₹102 Cr |
| Operating profit | ₹-1 Cr | ₹-4 Cr | ₹3 Cr |
| Operating margin | -1.3% | -4.3% | 2.6% |
| Interest | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Depreciation | ₹6 Cr | ₹8 Cr | ₹8 Cr |
| Net profit | ₹-4 Cr | ₹-20 Cr | ₹-2 Cr |
| Net margin | -5.7% | -21.5% | -1.9% |
| Cash from operations | ₹-9 Cr | ₹-5 Cr | ₹-3 Cr |
| Free cash flow | ₹-33 Cr | ₹-14 Cr | ₹-15 Cr |
| ROCE | -2.0% | -5.0% | -1.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹64 Cr | ₹65 Cr | ₹78 Cr | ₹78 Cr | ₹86 Cr | ₹87 Cr |
| Reserves | ₹127 Cr | ₹125 Cr | ₹96 Cr | ₹92 Cr | ₹88 Cr | ₹88 Cr |
| Borrowings | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹5 Cr | ₹11 Cr | ₹15 Cr |
| Other liabilities | ₹21 Cr | ₹19 Cr | ₹39 Cr | ₹22 Cr | ₹23 Cr | ₹26 Cr |
| Total liabilities | ₹215 Cr | ₹211 Cr | ₹215 Cr | ₹197 Cr | ₹207 Cr | ₹216 Cr |
| Fixed assets | ₹59 Cr | ₹55 Cr | ₹65 Cr | ₹90 Cr | ₹88 Cr | ₹89 Cr |
| Capital work in progress | ₹9 Cr | ₹16 Cr | ₹9 Cr | ₹1 Cr | ₹3 Cr | ₹4 Cr |
| Investments | ₹14 Cr | ₹15 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹5 Cr |
| Other assets | ₹133 Cr | ₹125 Cr | ₹139 Cr | ₹103 Cr | ₹111 Cr | ₹117 Cr |
| Total assets | ₹215 Cr | ₹211 Cr | ₹215 Cr | ₹197 Cr | ₹207 Cr | ₹216 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, FIIs added +1.55 pp while the public trimmed −0.83 pp.
- Promoters
- 33.9%
- FIIs
- 3.1%
- Public
- 63.0%
Since Jun 2025
- FIIs +1.55 pp
- Public −0.83 pp
- Promoters −0.71 pp
How it drifted, 12 quarters
Over this window promoters fell from 37.7% to 33.9% — −3.9 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 37.7%, Public 62.3%.Dec '23: Promoters 37.7%, DIIs 9.2%, Public 53.1%.Mar '24: Promoters 37.7%, FIIs 2.3%, DIIs 6.2%, Public 53.8%.Jun '24: Promoters 37.7%, FIIs 0.1%, DIIs 6.0%, Public 56.0%.Sep '24: Promoters 34.6%, FIIs 1.7%, Public 63.8%.Dec '24: Promoters 34.6%, FIIs 1.6%, Public 63.9%.Mar '25: Promoters 34.6%, FIIs 1.6%, Public 63.8%.Jun '25: Promoters 34.6%, FIIs 1.6%, Public 63.9%.Sep '25: Promoters 34.6%, FIIs 1.6%, Public 63.9%.Dec '25: Promoters 34.6%, FIIs 1.6%, Public 63.9%.Mar '26: Promoters 33.9%, FIIs 3.6%, Public 62.6%.Jun '26: Promoters 33.9%, FIIs 3.1%, Public 63.0%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Padma Khandu Solanki +0.18 pp 1.18% held
- Harish Chander Nanda newly disclosed 0.02% held
The same filing shows 1 holder trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of JHS Svendgaard Laboratories Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Nikhil Nanda | 30.32% | unchanged |
| Sushma Nanda | 3.51% | unchanged |
| Vijay Mohan Govila | 2.74% | unchanged |
| Vic Enterprises Private Limited | 2.06% | unchanged |
| Coeus Global Opportunities Fund FPI fund | 2.06% | unchanged |
| Milky Investment And Trading Company | 2.06% | unchanged |
| Puran Associates Private Limited | 2.06% | unchanged |
| M B Finmart Private Limited | 2.06% | unchanged |
| Bhim Sain Bassi | 1.51% | unchanged |
| Padma Khandu Solanki | 1.18% | +0.18 pp |
| Aegis Investment Fund Pcc FPI fund | 1.08% | −0.45 pp |
| Harish Chander Nanda | 0.02% | newly disclosed |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse JHS Svendgaard Laboratories Limited
Guides on how to read this kind of business and the numbers that matter.